AbbVie Inc. Cost of Revenue 2011-2025 | ABBV
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is AbbVie Inc.'s current cost of revenue?
AbbVie Inc. (ABBV) annual cost of revenue for 2024 was $16.90B, a 17.20% decline from 2023. AbbVie Inc. cost of revenue for the quarter ending September 30, 2025 was $5.30B.
What was AbbVie Inc.'s cost of revenue in 2023?
AbbVie Inc. annual cost of revenue for 2023 was $20.41B, a 17.23% increase from 2022.
What was AbbVie Inc.'s cost of revenue in 2022?
AbbVie Inc. annual cost of revenue for 2022 was $17.41B, a 0.18% decline from 2021.
What is AbbVie Inc.'s 5-year cost of revenue CAGR?
AbbVie Inc. cost of revenue grew at a compound annual growth rate (CAGR) of 17.84% from FY2019 to FY2024, going from $7.44B to $16.90B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+17.8%
FY2019
$7.44B
→
FY2024
$16.90B
1112131415161718192021222324
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2024 | $16.90B | -17.2% | 10-K |
| FY2023 | $20.41B | +17.2% | 10-K |
| FY2022 | $17.41B | -0.2% | 10-K |
| FY2021 | $17.45B | +13.4% | 10-K |
| FY2020 | $15.39B | +106.8% | 10-K |
| FY2019 | $7.44B | -3.6% | 10-K |
| FY2018 | $7.72B | +9.6% | 10-K |
| FY2017 | $7.04B | +20.7% | 10-K |
| FY2016 | $5.83B | +29.6% | 10-K |
| FY2015 | $4.50B | +1.7% | 10-K |
| FY2014 | $4.43B | -3.4% | 10-K |
| FY2013 | $4.58B | +1.6% | 10-K |
| FY2012 | $4.51B | -2.8% | 10-K |
| FY2011 | $4.64B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →